Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)

  1. Maroto, J.P.
  2. Del Muro, X.G.
  3. Mellado, B.
  4. Perez-Gracia, J.L.
  5. Andrés, R.
  6. Cruz, J.
  7. Gallardo, E.
  8. Domenech, M.
  9. Arranz, J.A.
  10. Meana, J.A.
Aldizkaria:
Clinical and Translational Oncology

ISSN: 1699-048X,  1699-3055

Argitalpen urtea: 2013

Alea: 15

Zenbakia: 9

Orrialdeak: 698-704

Mota: Artikulua

DOI: 10.1007/S12094-012-0991-Z GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus